BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22242678)

  • 1. Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1) -antihistamine dose escalation.
    Magerl M; Pisarevskaja D; Staubach P; Martus P; Church MK; Maurer M
    Br J Dermatol; 2012 May; 166(5):1095-9. PubMed ID: 22242678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study.
    Siebenhaar F; Degener F; Zuberbier T; Martus P; Maurer M
    J Allergy Clin Immunol; 2009 Mar; 123(3):672-9. PubMed ID: 19201016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
    Weller K; Ardelean E; Scholz E; Martus P; Zuberbier T; Maurer M
    Acta Derm Venereol; 2013 Mar; 93(2):168-74. PubMed ID: 23053062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
    Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Soccio AL; Ferrannini A; Vacca A
    Br J Dermatol; 2006 Dec; 155(6):1279-82. PubMed ID: 17107402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
    Augustin M; Ehrle S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ortonne JP; Grob JJ; Auquier P; Dreyfus I
    Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
    Kruszewski J; Kłos K; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria.
    Choonhakarn C; Chaowattanapanit S; Julanon N
    Int J Dermatol; 2018 Apr; 57(4):423-427. PubMed ID: 29380864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
    Hong JB; Lee HC; Hu FC; Chu CY
    J Am Acad Dermatol; 2010 Nov; 63(5):e100-2. PubMed ID: 20950731
    [No Abstract]   [Full Text] [Related]  

  • 17. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    DuBuske L
    Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Ring J; Hein R; Gauger A; Bronsky E; Miller B
    Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
    Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.